Lensar Inc is a medical technology company focused on developing and commercializing advanced systems for vision correction procedures
Their flagship product is designed to enhance the precision and effectiveness of laser cataract surgery, offering surgeons innovative tools to improve patient outcomes. By integrating advanced imaging and software technologies, Lensar aims to streamline the surgical process while promoting better recovery and visual results for patients undergoing cataract surgery. The company is dedicated to advancing ophthalmic surgery through innovation and cutting-edge solutions in the field of eye care.
Alcon is set to acquire LENSAR Inc. in a $356 million deal. This acquisition includes LENSAR's advanced cataract laser technologies, boosting Alcon's offerings in femtosecond laser-assisted cataract surgery.
Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.
